Holen Sie sich die Stockscreener-App
270.99
1.28%
-3.52
Vorhandelsmarkt:
270.48
-0.51
-0.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$274.51
Offen:
$270.77
24-Stunden-Volumen:
1.03M
Relative Volume:
1.13
Marktkapitalisierung:
$39.68B
Einnahmen:
$5.15B
Nettoeinkommen (Verlust:
$1.40B
KGV:
28.50
EPS:
9.51
Netto-Cashflow:
$1.65B
1W Leistung:
-4.97%
1M Leistung:
-2.94%
6M Leistung:
+16.05%
1J Leistung:
+10.60%
1-Tages-Spanne:
$268.97
$273.63
1-Wochen-Bereich:
$268.97
$285.08
52-Wochen-Spanne:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
Firmenname
Resmed Inc
Sektor
Telefon
(858) 746-2400
Adresse
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Vergleichen Sie RMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
270.99 | 40.19B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ISRG
Intuitive Surgical Inc
|
469.07 | 169.67B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
188.15 | 55.31B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
78.27 | 39.46B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
243.74 | 17.76B | 2.96B | 487.70M | 344.00M | 6.68 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-01-16 | Eingeleitet | Goldman | Buy |
| 2025-01-10 | Eingeleitet | Piper Sandler | Neutral |
| 2024-12-13 | Eingeleitet | Stifel | Hold |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-09-18 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | Herabstufung | Needham | Buy → Hold |
| 2024-06-25 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-06-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Hochstufung | Needham | Hold → Buy |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Eingeleitet | UBS | Buy |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-01-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-09-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-08-15 | Herabstufung | CLSA | Buy → Outperform |
| 2022-08-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-31 | Hochstufung | Goldman | Neutral → Buy |
| 2022-01-28 | Hochstufung | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Hochstufung | CLSA | Outperform → Buy |
| 2022-01-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Hochstufung | Macquarie | Neutral → Outperform |
| 2021-10-22 | Hochstufung | CLSA | Underperform → Outperform |
| 2021-08-02 | Herabstufung | CLSA | Outperform → Sell |
| 2021-08-02 | Herabstufung | Needham | Buy → Hold |
| 2021-07-28 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Eingeleitet | RBC Capital Mkts | Underperform |
| 2021-06-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-06-22 | Hochstufung | Macquarie | Neutral → Outperform |
| 2021-06-22 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-06-21 | Bestätigt | Needham | Buy |
| 2021-06-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Hochstufung | CLSA | Sell → Outperform |
| 2021-05-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-04-30 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-03-16 | Hochstufung | Needham | Hold → Buy |
| 2020-11-02 | Hochstufung | UBS | Neutral → Buy |
| 2020-10-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Eingeleitet | CLSA | Underperform |
| 2020-01-31 | Herabstufung | UBS | Buy → Neutral |
| 2020-01-10 | Eingeleitet | Oppenheimer | Perform |
| 2019-11-22 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Hochstufung | UBS | Neutral → Buy |
| 2019-07-16 | Herabstufung | UBS | Buy → Neutral |
| 2019-05-06 | Hochstufung | UBS | Neutral → Buy |
| 2019-04-18 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Herabstufung | Goldman | Buy → Neutral |
| 2019-01-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Eingeleitet | Goldman | Buy |
Alle ansehen
Resmed Inc Aktie (RMD) Neueste Nachrichten
ResMed Inc.’s volatility index tracking explainedCEO Change & Daily Profit Maximizing Tips - Newser
Should you wait for a breakout in ResMed Inc.Trade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
Real time breakdown of ResMed Inc. stock performanceJuly 2025 Market Mood & Safe Entry Point Alerts - Newser
Pattern recognition hints at ResMed Inc. upsideJuly 2025 Summary & Daily Price Action Insights - Newser
Can ResMed Inc. outperform in the next rallyPortfolio Update Summary & Community Trade Idea Sharing - خودرو بانک
Using AI based signals to follow ResMed Inc.2025 Big Picture & Community Trade Idea Sharing Platform - Newser
Is ResMed Inc. forming a reversal pattern2025 Winners & Losers & Free Community Supported Trade Ideas - Newser
Can ResMed Inc. lead its sector in growthTrade Entry Summary & Accurate Trade Setup Notifications - خودرو بانک
Can ResMed Inc. recover in the next quarterFed Meeting & Advanced Technical Analysis Signals - Newser
ResMed CFO's Share Sales: A Window into Insider Sentiment and Market Strategy - AInvest
ResMed Inc Announces Proposed Sale of 3,000 Common Shares - TipRanks
ResMed Shares Fall 1.28% as Technical Downturn Overshadows Strong Fundamentals Trading Volume Ranks 393rd - AInvest
Is ResMed Inc.’s growth already priced inJuly 2025 Trade Ideas & Weekly High Return Forecasts - خودرو بانک
Is ResMed Inc. stock reversal real or fake2025 Pullback Review & Expert Curated Trade Ideas - Newser
What MACD and RSI say about ResMed Inc.2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - Newser
Stock Analysis | ResMed OutlookBearish Momentum Grows Amid Mixed Analyst Expectations - AInvest
ResMed Inc. stock trendline breakdownJuly 2025 Breakouts & Safe Capital Growth Tips - Newser
Published on: 2025-09-02 06:08:36 - خودرو بانک
What’s the analyst consensus on ResMed Inc.July 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Live market analysis of ResMed Inc.Analyst Upgrade & AI Based Buy and Sell Signals - Newser
Multi factor analysis applied to ResMed Inc.Market Risk Report & Community Trade Idea Sharing Platform - Newser
Will ResMed Inc. outperform during market ralliesJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - خودرو بانک
Can ResMed Inc. disrupt its industryGap Down & Expert Approved Momentum Trade Ideas - خودرو بانک
Visual analytics tools that track ResMed Inc. performanceJuly 2025 Update & Consistent Profit Alerts - Newser
Advanced analytics toolkit walkthrough for ResMed Inc.July 2025 PreEarnings & Intraday High Probability Alerts - Newser
Best data tools to analyze ResMed Inc. stockMarket Volume Report & Technical Analysis for Trade Confirmation - Newser
Can technical indicators confirm ResMed Inc.’s reversalWeekly Gains Report & Verified Swing Trading Watchlist - Newser
Predicting ResMed Inc. trend using moving averagesJuly 2025 Reactions & Verified Stock Trade Ideas - Newser
What’s next for ResMed Inc. stock priceDip Buying & Verified Momentum Stock Watchlist - Newser
Long term hold vs stop loss in ResMed Inc.Earnings Summary Report & Community Driven Trade Alerts - Newser
Regression analysis insights on ResMed Inc. performanceWeekly Profit Report & Verified Trade Idea Suggestions - Newser
Order Flow Trends Show Accumulation in ResMed Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Visualizing ResMed Inc. stock with heatmapsJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
What indicators show strength in ResMed Inc.Market Growth Review & Fast Exit and Entry Trade Guides - Newser
What machine learning models say about ResMed Inc.Weekly Trading Summary & AI Optimized Trade Strategies - Newser
Finanzdaten der Resmed Inc-Aktie (RMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):